CYNO Cynosure - Class A (MM)

New 10-Watt System Substantially Reduces Treatment Time; Ideal for High-Volume Aesthetic Laser Practices WESTFORD, Mass., June 7 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced the launch of a new, higher power Smartlipo LaserBodySculpting (SM) Workstation. The new 10-watt workstation is intended for high-volume aesthetic laser practices, allowing a physician to complete a typical laser-assisted liposuction procedure in about half the time as the original 6-watt workstation. "Cynosure's new 10-watt Smartlipo workstation allows me to treat patients quickly and efficiently, with the same level of safety and efficacy as the 6- watt system," said Bruce Katz, M.D., founder of New York's Juva Skin & Laser Center. "For example, an area of localized fat under the chin can be treated in about eight minutes with the 10-watt Smartlipo system, compared with about 15 minutes with the 6-watt workstation." Introduced by Cynosure in January, the minimally invasive Smartlipo workstation is an innovative system designed as an alternative to traditional liposuction in patients with smaller areas of localized fat. The system's proprietary pulsing format delivers laser energy that liquefies localized deposits of fat that is then removed through a cannula. In addition the laser energy coagulates the tissue, thereby sculpting body contours and tightening the skin. The procedure generally causes less bleeding, swelling and bruising than traditional liposuction, resulting in fewer complications and faster recovery. Cynosure received U.S. Food and Drug Administration clearance to market Smartlipo in the fourth quarter of 2006. According to cosmetic surgeon Robert Gotkin, M.D., co-director of Cosmetique in New York, "The introduction of its new, higher power Smartlipo reflects Cynosure's commitment to advance its customers' practices with innovative products designed for patient efficiency." "We believe the introduction of the 10-watt platform will accelerate the adoption of Smartlipo in the marketplace," said Cynosure President and Chief Executive Officer Michael Davin. "We have been very pleased with the response to Smartlipo. Due to the short and minimally invasive nature of the Smartlipo treatment, patients who may have never considered traditional liposuction are having Smartlipo procedures performed." "We believe that expanding our family of products with a more powerful version of the Smartlipo workstation will enhance our competitive position," Davin said. "The faster treatment times afforded by this 10-watt platform will be attractive to medical professionals, particularly those with high- volume practices." The 10-watt Smartlipo workstation is available as a standalone unit or as an upgrade to the 6-watt system. Cynosure previously announced that it has added a 10-person specialty surgical sales force to market its Smartlipo family of workstations in North America. About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Safe Harbor Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., including statements about expectations related to the Company's Smartlipo LaserBodySculpting (SM) Workstation constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements contain the words "believes," "anticipates," "plans," "expects," "will" and similar expressions. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including Cynosure's history of operating losses, its reliance on sole source suppliers, the inability to accurately predict the success of the Smartlipo workstation, changes in consumer preferences, competition in the aesthetic laser industry as well economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K, which is filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release. DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., +1-617-542-5300, Web site: http://www.cynosure.com/

Copyright